Abstract
Acute ischemic stroke continues to be one of the leading causes of disability and death and is a financial burden to an already taxed health care system. Much research and investigation has been carried out over the past decade on various recanalization devices aimed at restoring cerebral blood flow. Despite the rapidly improving technical abilities of these devices, it has been difficult to demonstrate corresponding improved clinical outcomes. This article will describe the application of the most recent generation of these devices and briefly discuss the ongoing discrepancy between these technical achievements and stroke outcomes.
Keywords:
stent retriever; stroke; thrombolysis.
MeSH terms
-
Brain Ischemia / diagnosis
-
Brain Ischemia / mortality
-
Brain Ischemia / physiopathology
-
Brain Ischemia / therapy*
-
Cerebrovascular Circulation
-
Endovascular Procedures* / adverse effects
-
Endovascular Procedures* / methods
-
Endovascular Procedures* / mortality
-
Fibrinolytic Agents / administration & dosage*
-
Fibrinolytic Agents / adverse effects
-
Humans
-
Infusions, Intra-Arterial
-
Infusions, Intravenous
-
Risk Factors
-
Stroke / diagnosis
-
Stroke / mortality
-
Stroke / physiopathology
-
Stroke / therapy*
-
Thrombectomy* / adverse effects
-
Thrombectomy* / methods
-
Thrombectomy* / mortality
-
Thrombolytic Therapy* / adverse effects
-
Thrombolytic Therapy* / methods
-
Thrombolytic Therapy* / mortality
-
Treatment Outcome
Grants and funding
Funding/Support: The authors have no funding disclosures.